Clinical Trial Update: Study of TS-1 or TS-1 + PSK for Gastric Cancer Patients [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial evaluating TS-1 with or without PSK in gastric cancer. The current status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• PSK (polysaccharide-K)
• TS-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Tokyo Metropolitan Oncology Group | Conditions: Gastric Cancer | Phase 3 | Status: UNKNOWN